Notice2022-05801
Lead Exposure and Prevention Advisory Committee (LEPAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 21, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Lead Exposure and Prevention Advisory Committee (LEPAC). This is a virtual meeting and is open to the public. Advance registration by April 28, 2022, is needed to receive the information to join the meeting. The registration link is provided in the addresses section below.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 54 (Monday, March 21, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Page 16003]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-05801]
[[Page 16003]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee (LEPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This is a virtual meeting and is open to
the public. Advance registration by April 28, 2022, is needed to
receive the information to join the meeting. The registration link is
provided in the addresses section below.
DATES: The meeting will be held on May 12, 2022, from 9:00 a.m. to 4:30
p.m., EDT.
ADDRESSES: Register in advance at <a href="https://www.zoomgov.com/webinar/register/WN_JpapSgFXRKmeHVU9hW4jVQ">https://www.zoomgov.com/webinar/register/WN_JpapSgFXRKmeHVU9hW4jVQ</a> to receive information to join the
meeting.
FOR FURTHER INFORMATION CONTACT: Alexis Pullia, M.P.H., C.P.H.,
Committee Management Specialist, National Center for Environmental
Health, CDC, 4770 Buford Highway, Atlanta, Georgia 30341, Telephone:
770-488-3300; Email: <a href="/cdn-cgi/l/email-protection#fbb7beabbab8bb989f98d59c948d"><span class="__cf_email__" data-cfemail="8cc0c9dccdcfccefe8efa2ebe3fa">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-21,
Registry for Lead Exposure and Prevention Advisory Committee.
Purpose: The LEPAC is charged with providing advice and guidance to
the Secretary, Department of Health and Human Services (HHS), and the
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal
programs and services available to individual communities exposed to
lead; (2) reviewing current research on lead exposure to identify
additional research needs; (3) reviewing and identifying best
practices, or the need for best practices regarding lead screening and
the prevention of lead poisoning; (4) identifying effective services,
including services relating to healthcare, education, and nutrition for
individuals and communities affected by lead exposure and lead
poisoning, including in consultation with, as appropriate, the lead
exposure registry as established in Section 2203(b) of Public Law 114-
322; and 5) undertaking any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda will include updates on the
Flint Lead Registry and lead-related activities from LEPAC Members;
information on lead exposure in Clarksburg, West Virginia; and
discussions on the following: Infrastructure initiatives related to
lead; lead in air, soil, and blood; navigating multiple funding streams
at the local level; and policy approaches to improve childhood blood
lead testing rates. Agenda items are subject to change as priorities
dictate.
Public Participation
Oral Public Comment: The public comment period is scheduled on May
12, 2022, from 12:00 p.m. until 12:15 p.m., EDT. Individuals wishing to
make a comment during the public comment period, please email your
name, organization, and phone number by April 28, 2022, to
<a href="/cdn-cgi/l/email-protection#531f16031210133037307d343c25"><span class="__cf_email__" data-cfemail="5c10190c1d1f1c3f383f723b332a">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05801 Filed 3-18-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 21, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.